NEW YORK (GenomeWeb) – Opko Health today said that its proposed acquisition of Bio-Reference Laboratories has passed US antitrust review.

Early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 was granted yesterday, Opko said. The deal is still subject to other closing conditions including the approval of BRL's shareholders.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.